Clinical trial · Interventional
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
NCT06158932CI-TRIAL-00075662completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is a virtual single group study that will last 12 weeks. 40 female participants will take 4 capsules of the Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement per day. Questionnaires will be completed at Baseline, Week 4, Week 8 and Week 12. Participants will also provide a waist circumference measurement at Baseline and Week 12.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hormone Imbalance | — | UNRESOLVED | — |
| Polycystic Ovary Syndrome | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Myo Inositol and D-Chiro Inositol Supplement
- description
- Participants must take 4 capsules per day, with water. The product should be taken with the last meal of the day.
- interventionNames
- Dietary Supplement: Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement
Primary outcomes (4)
- measure
- Changes in menstrual cycle regularity. [Timeframe: Baseline to Week 12]
- timeFrame
- 12 weeks
- description
- Measured via study-specific questionnaires with participants reporting menstrual cycle occurrence and regularity during the trial.
- measure
- Changes in severity of menstrual cramps. [Timeframe: Baseline to Week 12]
- timeFrame
- 12 weeks
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 55 Years
Show eligibility criteria text
Inclusion Criteria: * Women aged between 18 - 55 * BMI less than 35 * Self-reported symptoms of PCOS like irregular periods, excessive hair growth, weight gain, oily skin, or acne * Self-reported concerns around irregular menstrual cycles and ovulation, mood swings, stress, irritability, and low energy * Self-reported concerns with hormonal skin issues * Has access to a tape measure for waist measurement * Generally healthy - don't live with any uncontrolled chronic disease Exclusion Criteria: * Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with known severe allergic reactions * Anyone who is pregnant or breastfeeding * Unwilling to follow the study protocol
References
Publications (0)
Data not yet available
No reference posted for this study.